Ditazole

Ditazole is a non-steroidal anti-inflammatory drug (NSAID) and a member of the phenyl-substituted 1,3‑oxazoles. It exhibits analgesic and antipyretic effects similar to phenylbutazone. In addition to its NSAID properties, ditazole acts as a platelet aggregation inhibitor and has been marketed in Spain and Portugal under the brand name Ageroplas for the prophylaxis and treatment of thrombotic vasculopathy or thromboembolic arteriosclerosis, hypertension, diabetes mellitus-related vascular complications (including nephropathy), vascular prostheses management, phlebitis, and thrombophlebitis[1][3][4]. Its mechanism involves inhibition of platelet aggregation.

Brand names

Ageroplas

Other names

DitazolDitazoloDitazolum2,2'-(4,5-Diphenyloxazol-2-ylazanediyl)diethanol2-[Bis(b-hydroxyethyl)amino]-4,5-diphenyloxazoleN-(4,5-Diphenyloxazol-2-yl)diethanolamine